scholarly journals Risk of adverse events with bevacizumab addition to therapy in advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials

2016 ◽  
pp. 2421 ◽  
Author(s):  
Han Yang ◽  
Xi-Xi Lai ◽  
Ren-Ai Xu ◽  
Yu-Ping Li
Sign in / Sign up

Export Citation Format

Share Document